BENGALURU: The Indian drug maker Cipla Ltd., on Wednesday, July 8, said that it has priced its generic version of remdesivir, Cipremi, at Rs 4,000 per 100 mg vial, which is among the lowest globally.
Nikhil Chopra, Executive Vice-President and CEO, Cipla India, in an emailed statement said that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month. He added the drug will only be available through government and hospital channels to ensure equitable distribution. As part of its efforts to help the society in this time of need, Cipla will also donate some of the medication.
Cipla’s Cipremi was authorised for restricted emergency use in the country by the Drug Controller General of India (DCGI) as part of the accelerated approval process, considering the urgent and unmet medical needs.
Representative Image NEW DELHI: Nitin Gadkari, Minister for Road Transport and Highways, Government of India,…
Representative Image GANDHINAGAR, Gujarat: Gujarat has reached a significant milestone in the construction of homes…
Representative Image THANE, Maharashtra: The Mira Bhayander Municipal Corporation (MBMC) in Maharashtra has established a…
Representative Image NEW DELHI: With the aim to tackle the increasing air pollution level in…
Representative Image LUCKNOW, Uttar Pradesh: The Uttar Pradesh State Industrial Development Authority (UPSIDA) has come…
Representative Image NEW DELHI: The Delhi Jal Board (DJB) plans to collaborate with the Water…